Correction: Kalkan et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina 2025, 61, 638
- PMID: 41303909
- PMCID: PMC12654801
- DOI: 10.3390/medicina61111997
Correction: Kalkan et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina 2025, 61, 638
Abstract
In the original publication, there was a mistake in Figure 2 as published [...].
Figures
Erratum for
-
Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study.Medicina (Kaunas). 2025 Mar 31;61(4):638. doi: 10.3390/medicina61040638. Medicina (Kaunas). 2025. PMID: 40282929 Free PMC article.
References
-
- Kalkan Z., Ebinc S., Arcagok M., Bilici A., Yildiz O., Kilickap S., Guven D.C., Tatli A.M., Sumbul A.T., Mandel N.M., et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina. 2025;61:638. doi: 10.3390/medicina61040638. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
